Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, clarifying that no new participants will be enrolled. In addition, the navigation labels and the page revision label were updated to reflect the current version (v3.6.0).
    Difference
    0.5%
    Check dated 2026-06-12T16:40:46.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.5, replacing v3.5.4, signaling a minor backend/content management update. No study content or results are affected.
    Difference
    0.1%
    Check dated 2026-06-05T12:47:08.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation or metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-05-15T05:09:27.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a new site version rather than a change to the study’s content.
    Difference
    0.1%
    Check dated 2026-04-23T21:53:05.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2, indicating a system update; no study content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-16T12:14:46.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Added Carcinoid tumor to MeSH terms and included a Resources section for Genetic and Rare Diseases Information Center. Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T21:56:07.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.